BioCryst Pharma (BCRX) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Price: $9.11 -1.94%
EPS Growth %: +6.7%
Financial Fact:
Total revenues: 7.76M
Today's EPS Names:
PEBK, DIT, AMC, More
EPS Growth %: +6.7%
Financial Fact:
Total revenues: 7.76M
Today's EPS Names:
PEBK, DIT, AMC, More
Join SI Premium – FREE
BioCryst Pharma (NASDAQ: BCRX) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $4.3 million.
For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
- CoastalSouth Bancshares, Inc. (COSO) Reports In-Line Q2 EPS
- Investar Holding (ISTR) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
